Related Experiment Video
Updated: Oct 27, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
Published on: April 14, 2022
Paraproteinaemic neuropathy: MGUS and beyond
Antonia S Carroll1,2, Michael P T Lunn3
1Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Paraproteinaemic neuropathies are diverse neuro-haematological disorders. Early diagnosis and multidisciplinary management are crucial to prevent delayed treatment, disability, and mortality in patients with these conditions.
Area of Science:
- Neurology
- Hematology
- Clinical Medicine
Background:
- Paraproteinaemic neuropathies represent a complex group of neuro-haematological disorders.
- Disease presentation ranges from mild sensory issues to severe sensorimotor deficits.
- Overlooking the haematological link can lead to delayed treatment and adverse outcomes.
Purpose of the Study:
- To provide a practical approach to diagnosing and managing paraproteinaemic disorders.
- To discuss the diagnostic utility and limitations of various tests.
- To highlight the importance of multidisciplinary care for these conditions.
Main Methods:
- Review of clinical phenotypes and diagnostic approaches.
- Discussion of haematological associations and their impact.
- Outline of multidisciplinary management strategies.
Main Results:
- Paraproteinaemic neuropathies exhibit diverse phenotypes and disease progression.
- Diagnostic tests have specific utilities and limitations.
- Inappropriate treatment can occur if benign paraproteins are mistaken for causative agents.
Conclusions:
- Accurate diagnosis requires careful consideration of both neurological and haematological aspects.
- Timely and appropriate management is essential for improving patient outcomes.
- A multidisciplinary approach is key to effectively managing these complex disorders.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Nephrotic Syndrome I : Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Nephrotic Syndrome II : Assessment and Medical Management
Proteoglycans